jens juul holst glp-1 New book by Professor about the history of 🎉 Find out more info about the book – and book reception – below 💡 Historien bag: Jens Juul Holst

Or are we looking at next-generation drugs that preserve muscle, or avoid more of the side effects a more standard development pathway

Patches are so easy to use: no mixing, no scheduling, no stacking multiple products

Researchers are now racing to develop new anti-obesity medications that are more effective, more convenient, or produce fewer side effects than the ones currently on the market

Retatrutide is a triple agonist (GLP-1, GIP, and glucagon receptors), which makes it considerably more powerful than semaglutide or even tirzepatide

82,83 In addition to lowering blood sugar levels, liraglutide helps to reduce body weight by suppressing appetite and reducing energy intake, 84,85 but its associated costs and need for daily injections may limit its use in individuals with obesity

This weeks column is by the UK College of Pharmacy Chief Practice Officer Brooke Hudspeth, Pharm.D